Baidu
map

Nature:研究揭示重复性脑创伤典型特征

2019-03-26 唐一尘 中国科学报

近日,英国研究人员描述了一种由重复性头部创伤(如运动伤害)引起的神经退行性疾病中的蛋白质组装。慢性创伤性脑部病变(CTE)的特征是tau 蛋白累积聚合,类似阿尔茨海默病一样。这项新研究表明,虽然影响这两种疾病的是同一种tau 蛋白,但CTE 中的tau 组装与阿尔茨海默病中的略有不同。以上发现证明,tau 组装的细微差异定义了不同的神经退行性疾病。

近日,英国研究人员描述了一种由重复性头部创伤(如运动伤害)引起的神经退行性疾病中的蛋白质组装。慢性创伤性脑部病变(CTE)的特征是tau 蛋白累积聚合,类似阿尔茨海默病一样。这项新研究表明,虽然影响这两种疾病的是同一种tau 蛋白,但CTE 中的tau 组装与阿尔茨海默病中的略有不同。以上发现证明,tau 组装的细微差异定义了不同的神经退行性疾病。

CTE 会影响从事接触性运动(如拳击和美式橄榄球)的运动员、退伍军人和遭受过身体虐待的人群。CTE 的症状包括行为、情绪和思维出现异常,一般在受伤后很长一段时间才会显现,而且会随着时间推移不断加重,甚至导致失智。虽然之前已经鉴定发现tau 蛋白组装对于CTE 进展有一定影响,但目前仍然缺乏对其结构的详细了解。

剑桥医学研究理事会分子生物学实验室的Sjors Scheres、Michel Goedert 及同事研究了3 名CTE 患者:一名美式橄榄球球员和两名拳击手,确定了3 人大脑中的tau 蛋白结构。他们发现3 人的tau 蛋白组装结构完全相同,但和其他涉及tau 蛋白组装的神经退行性疾病(如阿尔茨海默病)的患者不一样。相关论文近日在线发表于《自然》。

研究人员认为最新描述的tau 蛋白组装结构或有助于设计针对CTE 的诊断测试。该发现或许可以促进人们理解脑创伤是如何导致tau 蛋白形成的,进而帮助开发能够阻止CTE 中tau 蛋白积聚的疗法。

原始出处:

Benjamin Falcon, Jasenko Zivanov, Wenjuan Zhang, et.al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 20 March 2019

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1883640, encodeId=88721883640d9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 23 05:35:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751558, encodeId=81c91e5155859, content=<a href='/topic/show?id=713d95e399f' target=_blank style='color:#2F92EE;'>#重复性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95739, encryptionId=713d95e399f, topicName=重复性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced636322728, createdName=珙桐, createdTime=Sun Dec 29 03:35:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335254, encodeId=b4921335254e6, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Mar 28 09:35:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363634, encodeId=46a33636340c, content=向挑战病魔的科研人员致敬!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Wed Mar 27 14:26:50 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363622, encodeId=e2df363622a6, content=颅脑外伤与tau蛋白之间联系有研究吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhDSfjEXX0xXpx5burUgqy0FWOyrJ4HgnTPlKCIIJmIa0DKdYKNY4KtOcRmQdmmaHan4dphWcPeg/132, createdBy=481c2384909, createdName=zhangzhaoqi, createdTime=Wed Mar 27 10:30:36 CST 2019, time=2019-03-27, status=1, ipAttribution=)]
    2019-10-23 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1883640, encodeId=88721883640d9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 23 05:35:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751558, encodeId=81c91e5155859, content=<a href='/topic/show?id=713d95e399f' target=_blank style='color:#2F92EE;'>#重复性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95739, encryptionId=713d95e399f, topicName=重复性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced636322728, createdName=珙桐, createdTime=Sun Dec 29 03:35:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335254, encodeId=b4921335254e6, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Mar 28 09:35:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363634, encodeId=46a33636340c, content=向挑战病魔的科研人员致敬!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Wed Mar 27 14:26:50 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363622, encodeId=e2df363622a6, content=颅脑外伤与tau蛋白之间联系有研究吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhDSfjEXX0xXpx5burUgqy0FWOyrJ4HgnTPlKCIIJmIa0DKdYKNY4KtOcRmQdmmaHan4dphWcPeg/132, createdBy=481c2384909, createdName=zhangzhaoqi, createdTime=Wed Mar 27 10:30:36 CST 2019, time=2019-03-27, status=1, ipAttribution=)]
    2019-12-29 珙桐
  3. [GetPortalCommentsPageByObjectIdResponse(id=1883640, encodeId=88721883640d9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 23 05:35:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751558, encodeId=81c91e5155859, content=<a href='/topic/show?id=713d95e399f' target=_blank style='color:#2F92EE;'>#重复性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95739, encryptionId=713d95e399f, topicName=重复性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced636322728, createdName=珙桐, createdTime=Sun Dec 29 03:35:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335254, encodeId=b4921335254e6, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Mar 28 09:35:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363634, encodeId=46a33636340c, content=向挑战病魔的科研人员致敬!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Wed Mar 27 14:26:50 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363622, encodeId=e2df363622a6, content=颅脑外伤与tau蛋白之间联系有研究吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhDSfjEXX0xXpx5burUgqy0FWOyrJ4HgnTPlKCIIJmIa0DKdYKNY4KtOcRmQdmmaHan4dphWcPeg/132, createdBy=481c2384909, createdName=zhangzhaoqi, createdTime=Wed Mar 27 10:30:36 CST 2019, time=2019-03-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1883640, encodeId=88721883640d9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 23 05:35:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751558, encodeId=81c91e5155859, content=<a href='/topic/show?id=713d95e399f' target=_blank style='color:#2F92EE;'>#重复性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95739, encryptionId=713d95e399f, topicName=重复性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced636322728, createdName=珙桐, createdTime=Sun Dec 29 03:35:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335254, encodeId=b4921335254e6, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Mar 28 09:35:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363634, encodeId=46a33636340c, content=向挑战病魔的科研人员致敬!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Wed Mar 27 14:26:50 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363622, encodeId=e2df363622a6, content=颅脑外伤与tau蛋白之间联系有研究吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhDSfjEXX0xXpx5burUgqy0FWOyrJ4HgnTPlKCIIJmIa0DKdYKNY4KtOcRmQdmmaHan4dphWcPeg/132, createdBy=481c2384909, createdName=zhangzhaoqi, createdTime=Wed Mar 27 10:30:36 CST 2019, time=2019-03-27, status=1, ipAttribution=)]
    2019-03-27 坚强007

    向挑战病魔的科研人员致敬!!!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1883640, encodeId=88721883640d9, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 23 05:35:00 CST 2019, time=2019-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1751558, encodeId=81c91e5155859, content=<a href='/topic/show?id=713d95e399f' target=_blank style='color:#2F92EE;'>#重复性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95739, encryptionId=713d95e399f, topicName=重复性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ced636322728, createdName=珙桐, createdTime=Sun Dec 29 03:35:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335254, encodeId=b4921335254e6, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Thu Mar 28 09:35:00 CST 2019, time=2019-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363634, encodeId=46a33636340c, content=向挑战病魔的科研人员致敬!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5171668917, createdName=坚强007, createdTime=Wed Mar 27 14:26:50 CST 2019, time=2019-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363622, encodeId=e2df363622a6, content=颅脑外伤与tau蛋白之间联系有研究吗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhDSfjEXX0xXpx5burUgqy0FWOyrJ4HgnTPlKCIIJmIa0DKdYKNY4KtOcRmQdmmaHan4dphWcPeg/132, createdBy=481c2384909, createdName=zhangzhaoqi, createdTime=Wed Mar 27 10:30:36 CST 2019, time=2019-03-27, status=1, ipAttribution=)]
    2019-03-27 zhangzhaoqi

    颅脑外伤与tau蛋白之间联系有研究吗?

    0

相关资讯

eLife:震撼推出5篇重复性研究,直指**研究可重复性差

1月19日,eLife杂志在线出版了5篇研究论文,这些研究直指过去几年里肿瘤生物学领域广受瞩目的部分研究成果的可重复性非常差。 背景介绍: 2013年,一位名叫Elizabeth Iorns的80后女性肿瘤生物学家(University of Miami Miller School of Medicine助理教授)发起了一项“癌症生物领域重复性工程”(Reproducibility

新工具可计算生物医学论文可重复性得分

1 月 19 日公布的一个新的在线工具可通过分析已发表论文的引文数量,衡量该论文可再现性。

Baidu
map
Baidu
map
Baidu
map